P. Jänne

Oncology · 2004–2022

A researcher in the Science corpus: 38 papers; trusts 6 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Whom P. Jänne trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. William Pao

Who trusts P. Jänne overall

  1. J. Engelman
  2. Shang-Gin Wu
  3. N. Hynes
  4. C. Yun
  5. B. Chan
  6. William Pao

Papers from P. Jänne's perspective

Ordered by how strongly the researchers P. Jänne trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  2. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
  3. Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors (Clinical Cancer Research)
  4. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (PLoS Medicine)
  5. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. (New England Journal of Medicine)
  6. Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations. (Cancer Research)
  7. Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib (Clinical Cancer Research)
  8. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (PLoS Medicine)
  9. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. (Cancer Cell)
  10. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. (Journal of the National Cancer Institute)

Their papers